{
  "meta": {
    "title": "Hypersensitivity",
    "url": "https://brainandscalpel.vercel.app/hypersensitivity-77c78d94.html",
    "scrapedAt": "2025-11-30T11:13:36.301Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Contact dermatitis.</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Delayed type hypersensitivity.</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Immediate hypersensitivity.</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum sickness</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old male presents with rhinorrhea, nasal congestion, and persistent respiratory symptoms. He has noticed mold on the walls of his house. Skin testing for sensitivity to common mold spores gave positive results in less than 30 minutes. These findings indicate an example of:</span></p>",
      "unique_key": "DT1181773",
      "question_audio": null,
      "question_video": null,
      "map_id": 1181773,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Immediate hypersensitivity </strong>is indicated by the positive skin test results occurring in less than 30 minutes. This rapid onset is characteristic of Type I hypersensitivity reactions.</li>\n<li>Type I hypersensitivity is mediated by IgE antibodies, which are bound to the surface of mast cells via their Fc receptors. When allergens (like mold spores) cross-link these IgE antibodies on mast cell surfaces, it triggers the degranulation of mast cells and the rapid release of preformed inflammatory mediators, such as histamine. These mediators lead to the immediate symptoms observed, including rhinorrhea and nasal congestion in the respiratory tract.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250911fa7cf4ba-d2b3-4b56-b5ce-4a00693b461f.png\">\n<p><strong>Key Takeaway:</strong></p>\n<p>A <strong>rapid positive skin test result (within minutes) to an allergen like mold spores is a classic indicator of Immediate Hypersensitivity (Type I)</strong>, which is an IgE-mediated reaction involving mast cell degranulation and rapid release of inflammatory mediators.</p>",
      "correct_choice_id": 3,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Anaphylaxis</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Anergy.</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Antibody-mediated cytotoxicity.</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Contact sensitivity</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 20-year-old female with a history of penicillin allergy unknown to her treating doctor, was given a single injection of penicillin for the treatment of syphilis. Within minutes, she developed diffuse urticaria, tachycardia, and hypo-tension. This patient has experienced:</span></p>",
      "unique_key": "DT1181775",
      "question_audio": null,
      "question_video": null,
      "map_id": 1181775,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Anaphylaxis </strong>is the immediate and severe systemic allergic reaction described in the patient. This reaction is a classic example of Type I (immediate) hypersensitivity.</li>\n<li>Within minutes of re-exposure to penicillin (an allergen she was previously sensitized to), the patient experienced diffuse urticaria (hives), tachycardia (rapid heart rate), and hypotension (low blood pressure). These are hallmark signs of systemic anaphylaxis, characterized by sudden respiratory distress, hypotension, and tachycardia.</li>\n<li>This severe reaction is caused by the cross-linking of Fc$\\epsilon$RI-bound IgE antibodies on mast cell surfaces, triggering the rapid release of vasoactive amines and other mediators from mast cell granules throughout the body.</li>\n<li>Examples of Type I hypersensitivity include systemic anaphylaxis, and localized anaphylaxis (atopy) such as allergic rhinitis (hay fever), asthma, food allergy, atopic urticaria, atopic dermatitis (allergic eczema), and drug allergy.</li>\n<li>Experimental examples include P-K reaction, Schultz Dale phenomenon, and Theobald Smith phenomenon.</li>\n<li>Certain parasitic diseases (e.g., Tropical Pulmonary Eosinophilia, Loeffler's pneumonia, Ground itch, leakage of hydatid fluid, cercarial dermatitis) and parasitic tests (e.g., Casoni's test) are also associated with Type I reactions.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Anergy (Option B):</strong> Anergy is a mechanism that enables the immune system to not respond to an antigen, effectively silencing an immune response rather than causing an exaggerated one.</p>\n<p><strong>Antibody-mediated cytotoxicity (Option C):</strong> This refers to Type II hypersensitivity reactions, which are most often localized to specific tissues bearing epitopes to which the antibody binds, leading to direct cell damage or dysfunction, not the widespread systemic reaction seen.</p>\n<p><strong>Contact sensitivity (Option D):</strong> Contact sensitivity is a Type IV (delayed-type) hypersensitivity reaction that typically results from the epicutaneous application of a reactive antigen or hapten, causing a localized skin reaction that develops over 24-72 hours. In the present case, the antigen (penicillin) was administered intramuscularly, leading to a systemic, immediate reaction.</p>\n<p><strong>Key Takeaway:</strong> The rapid onset of severe, systemic symptoms including urticaria, tachycardia, and hypotension following re-exposure to an allergen like penicillin is the hallmark of <strong>anaphylaxis, a life-threatening Type I immediate hypersensitivity reaction.</strong></p>",
      "correct_choice_id": 11,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Antigen binding to IgE dimers attached to FcR-bearing mast cells</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">FcR-bearing cells binding to host cells coated with IgG</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">IgG binding to extracellular matrix of the respiratory passages</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">IgM-mediated interaction with cell membranes of lymphocytes</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 7-year-old female with a known allergy to peanuts inadvertently ingests an ice-cream containing traces of peanuts. Within one hour, she develops diffuse erythema (redness of the skin) and urticaria associated with respiratory symptoms of shortness of breath and diffuse wheezing. These findings suggest which of the following events?</span></p>",
      "unique_key": "DT1181784",
      "question_audio": null,
      "question_video": null,
      "map_id": 1181784,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Antigen binding to IgE dimers attached to FcR-bearing mast cells (Option A)</strong> accurately describes the immediate (Type I) hypersensitivity reaction.</li>\n<li>This rapid response (within one hour) is triggered when the peanut allergen cross-links pre-existing IgE antibodies bound to Fc receptors on mast cells.</li>\n<li>This cross-linking causes mast cell degranulation, releasing potent mediators like histamine, leading to the observed symptoms of diffuse erythema, urticaria, shortness of breath, and wheezing.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250911245639e4-41ca-437a-b39f-f62ad1fbddcd.png\">\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>FcR-bearing cells binding to host cells coated with IgG (Option B):</strong> This mechanism is characteristic of Type II (cytotoxic) hypersensitivity, which typically involves cell destruction, not rapid systemic mast cell activation.</p>\n<p><strong>IgG binding to extracellular matrix of the respiratory passages (Option C):</strong> This relates to Type II or Type III (immune complex) hypersensitivity, involving tissue damage or immune complex deposition, not the immediate, IgE-mediated response described.</p>\n<p><strong>IgM-mediated interaction with cell membranes of lymphocytes (Option D):</strong> This describes specific roles of IgM antibodies in immune recognition or direct cell interactions, which do not lead to the rapid, widespread symptoms of anaphylaxis.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>The <strong>rapid onset of severe allergic symptoms (anaphylaxis) following allergen exposure is caused by the binding of antigens to IgE antibodies on mast cells</strong>, triggering their degranulation and release of inflammatory mediators.</p>",
      "correct_choice_id": 21,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Type-I hypersensitivity</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Type-II hypersensitivity</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Type-III hypersensitivity</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Type-IV hypersensitivity</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 7-year-old female with a known allergy to peanuts inadvertently ingests an ice cream containing traces of peanuts. Within one hour, she develops diffuse erythema (redness of the skin) and urticaria associated with respiratory symptoms of shortness of breath and diffuse wheezing. Recovered from this event, the next day, she went to play with a friend. The friend gave her a Japanese lacquered box as a gift.<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025091125e112b3-9e4d-4c2c-a394-11e58dfa866d.png\"><br>48 hours later, she developed itchiness and redness in hands with clear fluid vesicles on her right forearm. These findings suggest which type of hypersensitivity?</span></p>",
      "unique_key": "DT1181795",
      "question_audio": null,
      "question_video": null,
      "map_id": 1181795,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The patient's symptoms (anemia-like) combined with <strong>decreased hemoglobin and a positive direct Coomb's test</strong> strongly suggest a hemolytic anemia. The history of being on an antibiotic points towards a drug-induced hemolytic anemia. This clinical picture is characteristic of <strong>Type II hypersensitivity, mediated by IgG antibodies </strong>.</li>\n<li>In Type II hypersensitivity reactions, antibodies (typically IgG or IgM) are directed against antigens on the surface of cells or in the extracellular matrix. In drug-induced hemolytic anemia, the drug (or a metabolite) can act as a hapten, binding to the surface of red blood cells (RBCs) and forming a neoantigen. The immune system then produces antibodies (often IgG) against this drug-RBC complex.</li>\n<li>A positive direct Coomb's test specifically detects these antibodies (or complement components) bound to the surface of the patient's RBCs, confirming antibody-mediated destruction of red blood cells.</li>\n<li>Examples of Type II hypersensitivity reactions include blood transfusion reactions, erythroblastosis fetalis, autoimmune hemolytic anemia, drug-induced hemolytic anemia, pemphigus vulgaris, hyperacute graft rejection, and autoantibody-mediated diseases like Goodpasture syndrome and pernicious anemia.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250911a8c3747d-db35-4da7-87ab-5d81c0afe799.png\">\n<p><strong>Explanation of Other Options:</strong></p>\n<ul>\n<li><strong>Type I, mediated by IgG antibodies (Option A):</strong> Type I hypersensitivity is mediated by IgE antibodies and involves mast cell degranulation, leading to immediate allergic reactions like anaphylaxis, not primarily IgG-mediated cell destruction or a positive Coomb's test.</li>\n<li><strong>Type III, mediated by IgG antibodies (Option C) or Type III, mediated by IgG or IgM antibodies (Option D):</strong> Type III hypersensitivity involves the formation of soluble antigen-antibody (immune) complexes that deposit in tissues, leading to inflammation. While IgG and IgM antibodies are involved, it does not typically manifest as direct antibody binding to red blood cells leading to a positive direct Coomb's test or hemolytic anemia. Goodpasture syndrome is an example of Type II, not Type III, as it involves antibodies directly targeting basement membranes.</li>\n</ul>\n<p><strong>Key Takeaway:</strong></p>\n<p>A <strong>positive direct Coomb's test indicating antibody-mediated destruction of red blood cells, often drug-induced, is a hallmark of Type II hypersensitivity, primarily mediated by IgG antibodies</strong> recognizing antigens on cell surfaces.</p>",
      "correct_choice_id": 34,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Type I, mediated by IgG antibodies</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Type II, mediated by IgG antibodies</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Type III, mediated by IgG antibodies</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Type III, mediated by IgG or IgM antibodies</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old male presents with headache, fatigue, light-headedness, dyspnea, and tachycardia. Laboratory investigations reveal decreased hemoglobin and a positive direct Coomb's test. The patient is presently on an antibiotic for symptoms of upper respiratory infection. These findings suggest which of the following</span></p>",
      "unique_key": "DT1181798",
      "question_audio": null,
      "question_video": null,
      "map_id": 1181798,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The patient's presentation with anemia-like symptoms (headache, fatigue, light-headedness, dyspnea, tachycardia) along with <strong>decreased hemoglobin and a positive direct Coomb's test</strong> is highly indicative of hemolytic anemia. Given the history of antibiotic use, this strongly suggests a drug-induced hemolytic anemia, which falls under <strong>Type II hypersensitivity, mediated by IgG antibodies</strong>.</li>\n<li>In Type II hypersensitivity reactions, antibodies (commonly IgG or IgM) are directed against antigens present on the surface of cells or in the extracellular matrix. In this case, the antibiotic (or its metabolites) can bind to the surface of the patient's red blood cells (RBCs), acting as a hapten to form a neoantigen. The immune system then produces antibodies, typically IgG, against these modified RBCs.</li>\n<li>A positive direct Coomb's test confirms the presence of these antibodies (or complement) bound directly to the patient's RBCs, leading to their destruction.</li>\n<li>Examples of Type II hypersensitivity reactions include blood transfusion reactions, erythroblastosis fetalis, autoimmune hemolytic anemia, drug-induced hemolytic anemia, pemphigus vulgaris, hyperacute graft rejection, and specific autoantibody-mediated diseases such as Goodpasture syndrome, pernicious anemia, and rheumatic fever.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Type I, mediated by IgG antibodies (Option A):</strong> Type I hypersensitivity is mediated by IgE antibodies and involves mast cell degranulation, leading to immediate allergic reactions like anaphylaxis. It does not typically involve IgG antibodies mediating cell destruction or result in a positive Coomb's test.</p>\n<p><strong>Type III, mediated by IgG antibodies (Option C) or Type III, mediated by IgG or IgM antibodies (Option D):</strong> Type III hypersensitivity involves the formation of soluble antigen-antibody (immune) complexes that deposit in various tissues, causing inflammation and damage. While IgG and IgM antibodies are involved in immune complex formation, this mechanism differs from direct antibody binding to cell surfaces leading to a positive direct Coomb's test and hemolytic anemia.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>A <strong>positive direct Coomb's test in a patient with anemia, especially with a history of drug exposure, points to Type II hypersensitivity, which is characterized by IgG (or IgM) antibodies directly targeting antigens on cell surfaces, leading to cell destruction, such as drug-induced hemolytic anemia.</strong></p>",
      "correct_choice_id": 42,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Type I hypersensitivity reactions</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Type II hypersensitivity reactions</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Type III hypersensitivity reactions</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Type IV hypersensitivity reactions</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is triggered by an interaction between a host cell membrane and an IgM or IgG antibody, but never by an IgE antibody?</span></p>",
      "unique_key": "DT1181802",
      "question_audio": null,
      "question_video": null,
      "map_id": 1181802,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Type II hypersensitivity reactions </strong>are precisely defined by their mechanism involving the interaction between IgM or IgG antibodies and antigens located on the surface of host cell membranes or in the extracellular matrix.</li>\n<li>This antibody binding can lead to cell lysis through complement activation, Antibody-Dependent Cell-mediated Cytotoxicity (ADCC), or interference with cell function.</li>\n<li>IgE antibodies are not involved in triggering Type II reactions. Examples of Type II reactions include blood transfusion reactions, autoimmune hemolytic anemia, Goodpasture Syndrome, and drug-induced hemolytic anemia.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Type I hypersensitivity reactions (Option A):</strong> These reactions are primarily triggered by the binding of antigens to IgE antibodies, which are pre-bound to Fc receptors on mast cells and basophils, leading to immediate degranulation.</p>\n<p><strong>Type III hypersensitivity reactions (Option C):</strong> These reactions are triggered by the formation of soluble immune complexes (antigen-antibody complexes, usually involving IgG or IgM) that deposit in various tissues, leading to inflammation and tissue damage, rather than direct antibody binding to host cell membranes.</p>\n<p><strong>Type IV hypersensitivity reactions (Option D):</strong> These reactions are cell-mediated, primarily involving T lymphocytes (T-cells) and macrophages, and do not involve antibodies (IgM, IgG, or IgE) in their primary triggering mechanism.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>Type II hypersensitivity reactions are uniquely characterized by the direct binding of IgM or IgG antibodies to antigens on host cell membranes or extracellular matrix</strong>, leading to cellular damage or dysfunction, and specifically <strong>do not involve IgE antibodies</strong>.</p>",
      "correct_choice_id": 52,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Autoimmune hemolytic anemia</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Anaphylaxis</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Extrinsic Asthma</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Hay Fever</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Examples of Type-1 hypersensitivity includes all of the following except:</span></p>",
      "unique_key": "DT1181806",
      "question_audio": null,
      "question_video": null,
      "map_id": 1181806,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Autoimmune hemolytic anemia </strong>is an example of a <strong>Type II hypersensitivity reaction</strong>, not a Type I.</li>\n<li>In autoimmune hemolytic anemia, antibodies (typically IgG or IgM) are directed against antigens on the surface of the body's own red blood cells, leading to their destruction.</li>\n<li>Examples of Type I Hypersensitivity:\n<ul>\n<li>Experiments:\n<ul>\n<li>P-K reaction</li>\n<li>Schultz Dale phenomenon</li>\n<li>Theobald smith phenomenon</li>\n</ul>\n</li>\n<li>Systemic anaphylaxis<strong>(Option B)</strong></li>\n<li>Localized anaphylaxis (atopy) such as:\n<ul>\n<li>Allergic rhinitis (or hay fever)<strong>(Option D)</strong></li>\n<li>Asthma<strong>(Option C)</strong></li>\n<li>Food allergy</li>\n<li>Atopic urticarial</li>\n<li>Atopic dermatitis (allergic eczema)</li>\n<li>Drug allergy</li>\n<li>Wheal and flare reaction.</li>\n</ul>\n</li>\n<li>Parasitic diseases:\n<ul>\n<li>Tropical Pulmonary Eosinophilia (TPE)</li>\n<li>Loeffler's pneumonia (Ascaris)</li>\n<li>Ground itch (Hookworm)</li>\n<li>Leakage of hydatid fluid</li>\n<li>Cercarial dermatitis/swimmer's itch (Schistosoma).</li>\n</ul>\n</li>\n<li>Parasitic tests:\n<ul>\n<li>Casoni test (hydatid disease)</li>\n</ul>\n</li>\n</ul>\n</li>\n</ul>\n<p><strong>Key Takeaway:</strong></p>\n<p>While <strong>anaphylaxis, extrinsic asthma, and hay fever are all examples of Type I (immediate) hypersensitivity reactions</strong>, <strong>autoimmune hemolytic anemia is distinctly classified as a Type II (cytotoxic) hypersensitivity reaction</strong>, involving antibody-mediated destruction of cells.</p>",
      "correct_choice_id": 61,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">In vitro demonstration of Anaphylaxis</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Test to detect atopy</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Type V hypersensitivity reaction</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Test for allergic contact dermatitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">True statement regarding Schultz dale phenomenon is:</span></p>",
      "unique_key": "DT1181813",
      "question_audio": null,
      "question_video": null,
      "map_id": 1181813,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>In vitro demonstration of Anaphylaxis </strong>is the true statement regarding the Schultz-Dale phenomenon.</li>\n<li>This experimental method involves suspending an excised smooth muscle (like an intestinal loop or uterine strip) from a sensitized animal in a physiological solution.</li>\n<li>The addition of the specific allergen then causes the smooth muscle to contract, providing an <em>in vitro</em> (outside the living body) demonstration of the immediate hypersensitivity (anaphylactic) reaction.</li>\n<li>It is a classic example used to study Type I hypersensitivity. Other experimental examples of Type I hypersensitivity include the P-K reaction and the Theobald Smith phenomenon.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Test to detect atopy (Option B):</strong> While the Schultz-Dale phenomenon is related to Type I hypersensitivity (which includes atopy), it is an <em>in vitro</em> experimental model, not a routine clinical test to detect atopy in humans. Clinical tests to detect atopy include skin prick tests, Radio-immunosorbent Test (RIST) for total serum IgE, and Radio-allergosorbent Test (RAST) for allergen-specific IgE.</p>\n<p><strong>Type V hypersensitivity reaction (Option C):</strong> The Schultz-Dale phenomenon is a Type I hypersensitivity reaction. Type V hypersensitivity reactions are a specific subset of Type II hypersensitivity, characterized by antibodies directed against cellular receptors, leading to either overstimulation or inhibition of receptor function. Examples include Myasthenia Gravis (antibodies against Acetylcholine receptors) and Grave's Disease (antibodies against TSH receptors).</p>\n<p><strong>Test for allergic contact dermatitis (Option D):</strong> Allergic contact dermatitis is a Type IV (delayed-type) hypersensitivity reaction. The diagnostic test for allergic contact dermatitis is the Patch test, not the Schultz-Dale phenomenon.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>The <strong>Schultz-Dale phenomenon is a classical <em>in vitro</em> experimental model used to demonstrate and study the mechanisms of anaphylactic (Type I immediate) hypersensitivity</strong>, particularly the contraction of smooth muscle upon allergen exposure.</p>",
      "correct_choice_id": 71,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">IgA</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">IgG</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">IgM</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">IgE</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Type I hypersensitivity is mediated by:</span></p>",
      "unique_key": "DT1181818",
      "question_audio": null,
      "question_video": null,
      "map_id": 1181818,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>IgE </strong>is the antibody primarily responsible for mediating Type I hypersensitivity reactions.</li>\n<li>The mechanism of Type I hypersensitivity involves:\n<ul>\n<li><strong>Sensitization phase:</strong> Upon initial exposure to an antigen (allergen), the antigen is processed and presented by Antigen-Presenting Cells (APCs) to T-cells. This activates T-helper 2 (Th2) cells, which then secrete cytokines like IL-4. IL-4 acts on B-cells, prompting them to produce IgE antibodies. These IgE antibodies have a high affinity for Fc receptors (Fc$\\epsilon$RI) found on the surface of mast cells, especially at mucosal sites, effectively \"sensitizing\" these cells.</li>\n<li><strong>Effector phase:</strong> During subsequent exposure to the same allergen, the allergen binds to the IgE antibodies already attached to the mast cells. This cross-linking of IgE molecules triggers the rapid degranulation of the mast cells, leading to the immediate release of preformed primary mediators (e.g., histamine) and the synthesis and release of secondary mediators. These mediators cause the characteristic symptoms of Type I hypersensitivity, such as smooth muscle constriction, increased capillary permeability, and increased mucus secretion.</li>\n</ul>\n</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250911245639e4-41ca-437a-b39f-f62ad1fbddcd.png\">\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>IgA (Option A):</strong> IgA is primarily found in mucosal secretions and plays a crucial role in mucosal immunity, protecting against pathogens at entry points, but it does not mediate Type I hypersensitivity.</p>\n<p><strong>IgG (Option B):</strong> IgG antibodies are the most abundant antibodies in serum and are involved in various immune functions, including neutralization, opsonization, and complement activation. They are primarily associated with Type II and Type III hypersensitivity reactions, but not Type I.</p>\n<p><strong>IgM (Option C):</strong> IgM antibodies are the first antibodies produced in a primary immune response and are very efficient at activating complement. They are primarily associated with Type II and Type III hypersensitivity reactions, but not Type I.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>Type I hypersensitivity, characterized by immediate allergic reactions, is uniquely mediated by IgE antibodies</strong>, which bind to mast cells and trigger mediator release upon re-exposure to an allergen.</p>",
      "correct_choice_id": 84,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">A-1, B-2, C-3, D-4, E-5</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">A-2, B-1, C-3, D-5, E-4</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">A-3, B-1, C-2, D-4, E-5</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">A-3, B-1, C-2, D-5, E-4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the following;<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250911554f7e9d-b97e-4992-9b15-59bf8db3703b.png\"></span></p>",
      "unique_key": "DT1181824",
      "question_audio": null,
      "question_video": null,
      "map_id": 1181824,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The correct matching aligns each condition/test with its corresponding hypersensitivity type:</p>\n<ul>\n<li><strong>A) Bullous pemphigus - 2) Type II:</strong> This is an autoimmune dermatological condition where antibodies are produced against hemi-desmosomes. These antibodies directly target and affect structural proteins in the skin, classifying it as a Type II Hypersensitivity Reaction.</li>\n<li><strong>B) Casoni's test - 1) Type I:</strong> This is a diagnostic skin test for hydatid disease. Upon intradermal injection of cystic fluid, if IgE antibodies are present and react, an immediate wheal and flare response (induration) occurs, which is characteristic of a Type I Hypersensitivity Reaction.</li>\n<li><strong>C) Berger&rsquo;s disease - 3) Type III:</strong> Also known as IgA nephropathy, this is a form of glomerulonephritis. It involves the formation of immune complexes composed of abnormal IgA and IgG antibodies. These antigen-antibody complexes then deposit in the kidney's glomeruli, leading to inflammation and damage, making it a Type III Hypersensitivity Reaction.</li>\n<li><strong>D) Grave&rsquo;s disease - 5) Type V:</strong> This is an autoimmune thyroid condition characterized by the production of activating autoantibodies that specifically target and stimulate the Thyroid-Stimulating Hormone (TSH) receptor. This stimulation leads to hyperthyroidism and associated eye pathology. Hypersensitivity reactions involving antibodies against cellular receptors are classified as Type V Hypersensitivity Reactions.</li>\n<li><strong>E) Contact dermatitis - 4) Type IV:</strong> This is a localized inflammatory reaction that typically develops approximately 48 hours after skin contact with a sensitizing chemical (e.g., nickel, hair dyes). This is a T-cell mediated response, making it a Type IV Hypersensitivity Reaction.</li>\n</ul>",
      "correct_choice_id": 92,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Type - I hypersensitivity</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Type - II hypersensitivity</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Type - III hypersensitivity</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Type IV hypersensitivity</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A AB -VE blood group pregnant female came with complaints of decreased fetal movements. Her husband's blood group is A+ ve and her 1st child is A + ve . She didn't take anti-d medication for the 1st pregnancy. Which HSR is responsible for fetal distress in the given clinical scenario.</span></p>",
      "unique_key": "DT1181828",
      "question_audio": null,
      "question_video": null,
      "map_id": 1181828,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The clinical scenario describes an Rh-negative pregnant female who became sensitized during her first pregnancy with an Rh-positive child, as she did not receive anti-D medication. In her current pregnancy with an Rh-positive fetus, pre-existing maternal <strong>IgG antibodies</strong> (formed during the initial sensitization) cross the placenta. These antibodies then directly attack the Rh-positive red blood cells (RBCs) of the fetus, leading to their destruction (hemolysis).</li>\n<li>This condition is known as Hemolytic Disease of the Newborn (HDN) or erythroblastosis fetalis. The destruction of fetal RBCs results in anemia and can cause fetal distress, hydrops fetalis, or even fetal death.</li>\n<li>This mechanism, involving antibodies directly targeting and destroying host cells, is the defining characteristic of <strong>Type II hypersensitivity</strong>.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250911bf7b4be8-8d94-4270-88ce-d678f93e1cec.png\">\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Type - I hypersensitivity (Option A):</strong> This type is mediated by IgE antibodies and involves immediate allergic reactions, such as anaphylaxis or hay fever. It is not associated with hemolytic disease of the newborn.</p>\n<p><strong>Type - III hypersensitivity (Option C):</strong> This type involves the formation and deposition of soluble immune complexes in tissues, leading to inflammation and damage. It does not involve direct antibody-mediated destruction of red blood cells.</p>\n<p><strong>Type IV hypersensitivity (Option D):</strong> This type is cell-mediated (T-cell mediated) and does not involve antibodies. It typically manifests as delayed reactions like contact dermatitis, rather than antibody-mediated cell destruction.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>Hemolytic disease of the newborn (erythroblastosis fetalis), which arises from maternal IgG antibodies attacking fetal red blood cells due to Rh incompatibility, is a classic example of a <strong>Type II hypersensitivity reaction</strong>, characterized by antibody-mediated cytotoxicity against host cells.</p>",
      "correct_choice_id": 102,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Contact dermatitis</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Hemolytic anemia</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum sickness</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Goodpasture's syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which is an example of type-III hypersensitivity:</span></p>",
      "unique_key": "DT1181831",
      "question_audio": null,
      "question_video": null,
      "map_id": 1181831,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Serum sickness</strong> is a classic example of a Type III hypersensitivity reaction.</li>\n<li>Type III hypersensitivity is characterized by the formation of soluble antigen-antibody complexes (also known as immune complexes) that circulate in the bloodstream. When these complexes are formed in slight antigen excess, they can deposit in various tissues and blood vessels, leading to inflammation and tissue damage.</li>\n<li>Serum sickness typically develops after repeated exposure to foreign proteins (e.g., antitoxins from other species). The patient develops antibodies against these injected foreign sera, and the subsequent interaction forms immune complexes.</li>\n<li>Symptoms, which can appear several days to two weeks after exposure, often include fever, rash (urticaria, erythema), joint pain (arthralgia), lymphadenopathy, malaise, and sometimes more severe manifestations like hypotension, splenomegaly, and glomerulonephritis. Discontinuation of the offending agent usually leads to resolution of symptoms within 4-5 days.</li>\n<li>Other examples of Type III hypersensitivity include Arthus reaction (localized, e.g., insect bites, Farmer's lung), Systemic Lupus Erythematosus (SLE), Hypersensitivity Pneumonitis, Rheumatoid Arthritis (which can involve both Type III and Type IV mechanisms), Type 2 Lepra Reaction, Polyarteritis Nodosa (PAN), and Post-Streptococcal Glomerulonephritis (PSGN).</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Contact dermatitis (Option A):</strong> This is a Type IV hypersensitivity reaction, which is cell-mediated by T cells and involves a delayed reaction (typically 48 hours after exposure), not immune complex deposition.</p>\n<p><strong>Hemolytic anemia (Option B):</strong> This is generally a Type II hypersensitivity reaction, where antibodies directly target and cause the lysis of red blood cells.</p>\n<p><strong>Goodpasture's syndrome (Option D):</strong> This is a Type II hypersensitivity reaction, characterized by autoantibodies specifically directed against the &alpha;3 chain of Type IV collagen in the basement membranes of the kidneys and lungs. This is an example of direct antibody-mediated tissue damage, not immune complex deposition.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>Serum sickness is a hallmark example of Type III hypersensitivity, where symptoms are caused by the deposition of circulating immune complexes in tissues</strong>, leading to systemic inflammation and diverse clinical manifestations like fever, rash, and joint pain.</p>",
      "correct_choice_id": 113,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum sickness</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Farmer's lungs</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">SLE</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Graft rejection</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following are immune complex disease except:</span></p>",
      "unique_key": "DT1181834",
      "question_audio": null,
      "question_video": null,
      "map_id": 1181834,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Graft rejection </strong>is the exception among the listed options. While graft rejection encompasses various types of immune responses, it is not primarily classified as an immune complex (Type III) disease.</li>\n<li>Hyperacute graft rejection is primarily a Type II hypersensitivity (antibody-mediated), whereas acute and chronic graft rejection, and Graft-versus-Host Disease (GvHD), are largely Type IV hypersensitivity (cell-mediated) reactions.</li>\n<li>This makes it distinct from the other conditions, which are classic examples of immune complex diseases.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Serum sickness (Option A):</strong> This is a classic example of a Type III hypersensitivity reaction, caused by the formation and deposition of circulating immune complexes in various tissues, leading to systemic symptoms like fever, rash, and arthralgia.</p>\n<p><strong>Farmer's lungs (Option B):</strong> This is a form of hypersensitivity pneumonitis, specifically caused by repeated inhalation of antigens (like <em>Saccharopolyspora</em> species) found in moldy hay. It involves the formation of immune complexes in the lungs, leading to inflammation, and is thus an example of a localized Type III hypersensitivity (Arthus reaction in the lungs).</p>\n<p><strong>SLE (Systemic Lupus Erythematosus) (Option C):</strong> This is a prototypic autoimmune disease largely mediated by Type III hypersensitivity. It involves the production of numerous autoantibodies that form immune complexes, which then deposit in various organs (e.g., kidneys, joints, skin), leading to widespread inflammation and tissue damage.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>While serum sickness, Farmer's lung, and Systemic Lupus Erythematosus (SLE) are all well-established examples of immune complex (Type III) diseases, graft rejection involves a broader range of hypersensitivity types, predominantly Type II and Type IV, and is not solely classified as an immune complex disease.</p>",
      "correct_choice_id": 124,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Type 1</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Type 2</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Type 3</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Type 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A person came with complaints of hypopigmented patches over the body along with loss of sensation. Biopsy reveals presence of foamy macrophages loaded with lepra bacilli. After initiation of treatment, he developed fever, joint pains, and new red & tender lesions all over body. Which type of hypersensitivity reaction has happened to him?</span></p>",
      "unique_key": "DT1181841",
      "question_audio": null,
      "question_video": null,
      "map_id": 1181841,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The patient's initial symptoms (hypopigmented patches, loss of sensation, foamy macrophages with lepra bacilli on biopsy) indicate a diagnosis of leprosy. The subsequent development of fever, joint pains, and new red &amp; tender lesions all over the body <strong>after initiating treatment</strong> is characteristic of a <strong>Type 2 Lepra Reaction</strong>, also known as Erythema Nodosum Leprosum (ENL).</li>\n<li><strong>Type 2 Lepra Reaction is a Type III hypersensitivity reaction</strong>. This reaction occurs due to the rapid release of large amounts of <em>Mycobacterium leprae</em> antigens from dying bacilli after starting treatment. These antigens then form immune complexes with pre-existing antibodies, which deposit in various tissues, including blood vessels and joints. This deposition triggers an inflammatory response, leading to systemic symptoms like fever and arthralgia, and the characteristic tender skin nodules.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250911f7a3a3d7-6d87-4ce2-a0f1-56150c5e6920.png\">\n<ul>\n<li>A helpful mnemonic for remembering the types of hypersensitivity for Lepra Reactions is: Type 1 Lepra Reaction = Type 4 HSR, and Type 2 Lepra Reaction = Type 3 HSR.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250911e5c94de3-d0eb-46dc-8db8-28ffac2913d2.png\">\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Type 1 (Option A):</strong> This type is an immediate, IgE-mediated allergic reaction (e.g., anaphylaxis) and does not explain the delayed, systemic, immune complex-mediated nature of the described reaction.</p>\n<p><strong>Type 2 (Option B):</strong> This type involves antibodies directly targeting cell surfaces or extracellular matrix components (e.g., hemolytic anemia) and does not match the clinical features of immune complex deposition.</p>\n<p><strong>Type 4 (Option D):</strong> This type is a T-cell mediated delayed-type hypersensitivity reaction (e.g., contact dermatitis). While Type 1 Lepra Reaction is a Type IV HSR, the patient's symptoms of fever, joint pain, and new tender nodules are specific to a Type 2 Lepra Reaction, which is a Type III HSR.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>The occurrence of <strong>fever, joint pains, and new tender red lesions (Erythema Nodosum Leprosum) in a leprosy patient after starting treatment signifies a Type 2 Lepra Reaction, which is an immune complex-mediated (Type III) hypersensitivity reaction.</strong><br /> </p>",
      "correct_choice_id": 133,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Type 1</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Type 2</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Type 3</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Type 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A CKD patient is planned for renal transplant. The surgeon noticed the kidney became floppy and dusky immediately after transplantation. The hypersensitivity reaction involved in this scenario is;</span></p>",
      "unique_key": "DT1181844",
      "question_audio": null,
      "question_video": null,
      "map_id": 1181844,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The scenario describes a renal allograft becoming \"floppy and dusky immediately after transplantation,\" which is characteristic of <strong>hyperacute graft rejection</strong>. This rapid and severe form of rejection is mediated by <strong>Type II hypersensitivity</strong>.</li>\n<li>Hyperacute rejection occurs when the recipient has pre-formed antibodies (typically IgM or IgG) against donor antigens, particularly ABO blood group antigens or Human Leukocyte Antigens (HLAs). These antibodies, present in the recipient's circulation before transplantation, immediately bind to antigens on the vascular endothelium of the transplanted organ.</li>\n<li>This binding triggers rapid complement activation and coagulation cascade, leading to widespread thrombosis, ischemia, and necrosis within the graft. The immediate onset and visible changes in the organ (floppy and dusky appearance) are hallmarks of this antibody-mediated reaction. Histopathology typically reveals fibrinoid necrosis of vessels.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025091182f266c4-6a92-4822-a347-9d67b6ab8e82.png\">\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Type 1 (Option A):</strong> Type 1 hypersensitivity is an immediate, IgE-mediated allergic reaction (e.g., anaphylaxis). It is not involved in graft rejection.</p>\n<p><strong>Type 3 (Option C):</strong> Type 3 hypersensitivity involves the formation and deposition of soluble immune complexes in tissues, leading to inflammation. While immune complexes can play a role in some forms of transplant pathology, they are not the primary mechanism of hyperacute rejection.</p>\n<p><strong>Type 4 (Option D):</strong> Type 4 hypersensitivity is a cell-mediated (T-cell mediated) delayed-type reaction. This type is primarily responsible for acute and chronic graft rejection, which occur days to weeks or months after transplantation, not immediately.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>The immediate (minutes to hours) and severe deterioration of a transplanted organ, resulting in a floppy and dusky appearance, is characteristic of <strong>hyperacute graft rejection, which is a Type II hypersensitivity reaction mediated by pre-formed antibodies</strong> in the recipient against donor</p>",
      "correct_choice_id": 142,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">B lymphocytes</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">NK cells</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Mast cells</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">T lymphocytes</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Delayed hypersensitivity reaction is mediated by:</span></p>",
      "unique_key": "DT1181845",
      "question_audio": null,
      "question_video": null,
      "map_id": 1181845,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>T lymphocytes</strong> are the primary mediating cells in delayed hypersensitivity reactions (Type IV hypersensitivity).</li>\n<li>These reactions are characterized by a delayed onset, typically occurring 24 to 72 hours after exposure to an antigen.</li>\n<li>In this type of immune response, T helper cells (CD4+ cells) recognize antigens presented by antigen-presenting cells (like dendritic cells or macrophages). Upon recognition, these T cells release various cytokines that activate other immune cells, particularly macrophages, leading to an inflammatory response and tissue damage at the site of antigen exposure.</li>\n<li>Examples of Type IV hypersensitivity reactions include contact dermatitis (e.g., to poison ivy, nickel), the tuberculin skin test, Type 1 Lepra Reaction, granuloma formation (e.g., in tuberculosis, sarcoidosis), and certain autoimmune diseases like Type 1 diabetes mellitus, multiple sclerosis, Hashimoto's thyroiditis, Graft-versus-Host Disease, and Crohn's disease.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>B lymphocytes (Option A):</strong> B lymphocytes are primarily responsible for humoral immunity, specifically the production of antibodies (IgA, IgG, IgM, IgE) and are involved in Type I, II, and III hypersensitivity reactions, not delayed hypersensitivity.</p>\n<p><strong>NK cells (Option B):</strong> Natural Killer (NK) cells are part of the innate immune system and are involved in targeting and destroying virus-infected cells and tumor cells, but they are not the primary mediators of delayed hypersensitivity reactions.</p>\n<p><strong>Mast cells (Option C):</strong> Mast cells play a central role in immediate (Type I) hypersensitivity reactions by releasing preformed mediators like histamine upon cross-linking of IgE antibodies by allergens, leading to rapid allergic symptoms. They are not involved in delayed hypersensitivity.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>Delayed hypersensitivity reactions (Type IV HSR) are primarily mediated by T lymphocytes</strong>, which, upon antigen re-exposure, release cytokines that orchestrate an inflammatory response and tissue damage with a delayed onset.</p>",
      "correct_choice_id": 154,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Arthus reaction</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum sickness</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Schwartzmann reaction</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Granulomatous reaction</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An example of Type IV hypersensitivity is:</span></p>",
      "unique_key": "DT1181848",
      "question_audio": null,
      "question_video": null,
      "map_id": 1181848,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Granulomatous reaction </strong>is a hallmark example of Type IV hypersensitivity, specifically a chronic form of delayed-type hypersensitivity.</li>\n<li>Type IV hypersensitivity is cell-mediated, primarily involving T-lymphocytes (specifically TDTH cells) and activated macrophages.</li>\n<li>It is characterized by a delayed onset, occurring 24-72 hours or even weeks after antigen exposure.</li>\n<li>When persistent antigens (like those from <em>Mycobacterium tuberculosis</em> or certain fungi) or foreign bodies cannot be cleared, the prolonged activation of macrophages and lymphocytes leads to the formation of granulomas.</li>\n<li>These are organized collections of macrophages (often epithelioid cells) and T lymphocytes, surrounded by fibroblasts, designed to wall off the offending agent.</li>\n<li>Tissue injury in granulomatous reactions is predominantly due to the sustained release of mediators from activated macrophages.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Arthus reaction (Option A):</strong> This is a localized example of a Type III hypersensitivity reaction. It involves the formation of immune complexes that deposit in blood vessel walls at the site of antigen injection, leading to local inflammation, edema, and hemorrhage.</p>\n<p><strong>Serum sickness (Option B):</strong> This is a systemic example of a Type III hypersensitivity reaction, caused by the widespread deposition of circulating immune complexes in various tissues and organs, leading to symptoms like fever, rash, and joint pain.</p>\n<p><strong>Schwartzman reaction (Option C):</strong> This is an inflammatory process related to endotoxin exposure and is primarily considered a Type III hypersensitivity reaction, although its mechanisms also involve massive complement activation and cytokine release, leading to disseminated intravascular coagulation and necrotic lesions. It involves antigen-antibody complex deposition leading to thrombi and necrosis.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>Granulomatous reactions are a characteristic manifestation of chronic Type IV (delayed-type) hypersensitivity</strong>, where persistent antigen stimulation leads to the sustained activation of T lymphocytes and macrophages, forming organized cellular aggregates (granulomas) to contain the insoluble or difficult-to-clear substances.</p>",
      "correct_choice_id": 164,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Type 1 hypersensitivity mediated by CD4+ T cells</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Type 2 hypersensitivity mediated by IgM</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Type 3 hypersensitivity mediated by IgG</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">Type 4 hypersensitivity mediated by IgG and sometimes IgM</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old female with hepatitis C viral infection presents with decreased renal function, hypertension, and anemia. Laboratory findings decreased serum C3 and urine sediment containing leukocytes, erythrocytes, and red blood cell casts. Her renal biopsy demonstrates changes consistent with glomerulonephritis. These findings suggest which type of hypersensitivity?</span></p>",
      "unique_key": "DT1181855",
      "question_audio": null,
      "question_video": null,
      "map_id": 1181855,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The patient's presentation, including decreased renal function, hypertension, anemia, and specifically <strong>glomerulonephritis with decreased serum C3 and red blood cell casts in urine</strong>, strongly suggests an immune complex-mediated disease. This clinical picture is highly consistent with <strong>Type III hypersensitivity mediated by IgG</strong>.</li>\n<li>Hepatitis C viral infection is known to be associated with cryoglobulinemic vasculitis, which often presents as immune complex glomerulonephritis. In Type III hypersensitivity, antigen-antibody complexes (often involving IgG, and sometimes IgM) form in the circulation and then deposit in various tissues, particularly the glomeruli of the kidneys.</li>\n<li>The deposition of these immune complexes activates the complement system, leading to the consumption of complement components (hence the decreased serum C3 levels).</li>\n<li>This activation attracts inflammatory cells, causing inflammation and damage to the glomeruli, which manifests as glomerulonephritis, red blood cell casts, and compromised renal function.</li>\n<li>It's important to note that most forms of glomerulonephritis, except Goodpasture's syndrome (which is Type II), are examples of Type III hypersensitivity.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Type 1 hypersensitivity mediated by CD4+ T cells (Option A):</strong> Type 1 hypersensitivity is mediated by IgE antibodies, leading to immediate allergic reactions. CD4+ T cells play a role in orchestrating the IgE response but are not direct mediators in the way described here. This type does not explain glomerulonephritis or decreased C3.</p>\n<p><strong>Type 2 hypersensitivity mediated by IgM (Option B):</strong> Type II hypersensitivity involves antibodies (IgM or IgG) directly binding to antigens on cell surfaces or extracellular matrix, leading to cell destruction or dysfunction (e.g., Goodpasture's syndrome, hemolytic anemia). While IgM can be involved in Type II, the clinical picture of circulating immune complexes depositing in glomeruli is more indicative of Type III.</p>\n<p><strong>Type 4 hypersensitivity mediated by IgG and sometimes IgM (Option D):</strong> Type IV hypersensitivity is cell-mediated, primarily by T lymphocytes, and does not involve antibodies in its direct mechanism. Therefore, it would not explain the presence of IgG, IgM, or immune complex deposition leading to glomerulonephritis.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>Glomerulonephritis with decreased serum complement levels and evidence of inflammation (like red blood cell casts) in a patient with a chronic infection (like Hepatitis C) strongly suggests an immune complex-mediated disease, which is characteristic of Type III hypersensitivity, often mediated by IgG antibodies.</p>",
      "correct_choice_id": 173,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">Types I and IV</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">Types II and IV</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Types II and III</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">Types III and IV</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following hypersensitivity types has neutrophils as important mediators of tissue damage?</span></p>",
      "unique_key": "DT1181858",
      "question_audio": null,
      "question_video": null,
      "map_id": 1181858,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Neutrophils are important mediators of tissue damage in Type II and Type III hypersensitivity reactions</strong>.</li>\n<li>In <strong>Type II hypersensitivity</strong>, where antibodies (IgG or IgM) bind directly to antigens on cell surfaces or extracellular matrices, the antibody-antigen complex can activate complement. This leads to the generation of anaphylatoxins (C3a, C5a) and opsonins (C3b, iC3b).</li>\n<li>C5a is a potent chemotactic factor for neutrophils, recruiting them to the site. Neutrophils then bind to cells opsonized with C3b or antibodies (via Fc receptors) and release their cytotoxic granule contents (e.g., lysosomal enzymes, reactive oxygen species), causing tissue injury.</li>\n<li>In <strong>Type III hypersensitivity</strong>, circulating immune complexes (antigen-antibody complexes) deposit in tissues and activate complement. This also generates complement fragments (like C5a) that are highly chemotactic for neutrophils.</li>\n<li>Neutrophils accumulate at the sites of immune complex deposition, attempt to phagocytose the complexes, and in doing so, release their lysosomal enzymes and reactive oxygen species into the surrounding tissue, leading to inflammation and damage.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Types I and IV (Option A):</strong> In Type I hypersensitivity, mast cells and basophils are the primary mediators of the immediate response through IgE. While neutrophils can be involved in the \"late phase\" of some Type I reactions, they are not primary mediators of the initial tissue damage. Type IV hypersensitivity is cell-mediated, primarily by T lymphocytes and macrophages, with neutrophils playing no significant direct role in the tissue damage.</p>\n<p><strong>Types II and IV (Option B):</strong> Type II involves neutrophils as described, but Type IV hypersensitivity is cell-mediated by T lymphocytes and macrophages, not neutrophils.</p>\n<p><strong>Types III and IV (Option D):</strong> Type III involves neutrophils as described, but Type IV hypersensitivity is cell-mediated by T lymphocytes and macrophages, not neutrophils.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>Neutrophils are key mediators of tissue damage in both Type II (antibody-mediated cellular destruction) and Type III (immune complex-mediated) hypersensitivity reactions</strong>, primarily through their release of cytotoxic granule contents upon activation by IgG complexes and complement fragments.</p>",
      "correct_choice_id": 183,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">It requires the cells to have IgE of only one antigenic specificity per cell</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">It is Ca2+ independent phenomenon</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">It cannot occur in the absence of antigen-specific IgE</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">It occurs after IgE Fc receptor crosslinking</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">True regarding Histamine release from mast cell granules:</span></p>",
      "unique_key": "DT1181864",
      "question_audio": null,
      "question_video": null,
      "map_id": 1181864,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>It occurs after IgE Fc receptor crosslinking </strong>is the correct statement.</li>\n<li>Histamine release from mast cell granules, a central event in Type I hypersensitivity, is primarily triggered when multivalent antigens (allergens) bind to and crosslink two or more IgE antibodies that are already bound to the high-affinity Fc receptors on the surface of mast cells.</li>\n<li>This crosslinking initiates a signaling cascade that leads to mast cell degranulation and the release of preformed mediators like histamine.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>It requires the cells to have IgE of only one antigenic specificity per cell (Option A):</strong> Mast cells and basophils express high-affinity Fc receptors for IgE, and these cells typically bind IgE antibodies of <em>many different antigenic specificities</em> on their surface. This allows them to respond to various allergens.</p>\n<p><strong>It is Ca2+ independent phenomenon (Option B):</strong> The signaling pathway initiated by IgE Fc receptor crosslinking involves an increase in intracellular calcium (Ca2+) levels, which is a crucial step for the degranulation process and release of histamine.</p>\n<p><strong>It cannot occur in the absence of antigen-specific IgE (Option C):</strong> While antigen-specific IgE and its crosslinking is the primary mechanism for allergic reactions, mast cells can also be triggered to release granule contents by other non-IgE mechanisms. For instance, complement anaphylatoxins (C3a and C5a) can directly bind to receptors on mast cells and induce degranulation, independent of IgE.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>The key event triggering <strong>histamine release from mast cell granules is the crosslinking of IgE Fc receptors</strong> on the mast cell surface by multivalent antigens, initiating a Ca2+-dependent signaling cascade. Mast cells can also be activated by other, non-IgE-dependent mechanisms.</p>",
      "correct_choice_id": 194,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\">1-d, 2-b, 3-a, 4-c</span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">1-a, 2-c, 3-b, 4-d</span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">1-d, 2-a, 3-b, 4-c</span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">1-c, 2-b, 3-a, 4-a</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the following;<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250911d8d8172f-763c-416d-92c7-11c18c8c33bb.png\"></span></p>",
      "unique_key": "DT1181867",
      "question_audio": null,
      "question_video": null,
      "map_id": 1181867,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The correct matching is as follows:</p>\n<ul>\n<li><strong>1) Lepromin test - d) Type 4 HSR:</strong> The Lepromin test is an intradermal skin test that assesses a patient's cell-mediated immune response to <em>Mycobacterium leprae</em> The reaction, which is delayed and involves granuloma formation, is a classic example of a Type 4 hypersensitivity reaction.</li>\n<li><strong>2) Goodpasture syndrome - b) Type 2 HSR:</strong> Goodpasture syndrome is an autoimmune disease where autoantibodies are produced against the &alpha;3 chain of Type IV collagen in the basement membranes of the kidneys and lungs. This direct antibody-mediated attack on host tissue is a hallmark of a Type 2 hypersensitivity reaction.</li>\n<li><strong>3) Schultz-Dale phenomenon - a) Type 1 HSR:</strong> The Schultz-Dale phenomenon is an <em>in vitro</em> experimental model for Type 1 hypersensitivity. It demonstrates that when an excised smooth muscle from a sensitized animal is exposed to an allergen, it contracts due to the IgE-mediated release of mediators from mast cells.</li>\n<li><strong>4) Lepra reaction 2 - c) Type 3 HSR:</strong> The Type 2 Lepra Reaction, also known as Erythema Nodosum Leprosum (ENL), is an immune complex-mediated disease. It occurs when immune complexes, formed from <em>Mycobacterium leprae</em> antigens and antibodies, deposit in blood vessel walls, leading to systemic inflammation and the characteristic fever, joint pains, and tender skin nodules.</li>\n</ul>\n<p><strong>Key Takeaway:</strong></p>\n<p>It is essential to understand the underlying mechanisms of each hypersensitivity type to correctly classify conditions and tests. The <strong>Lepromin test is a cell-mediated (Type 4) response</strong>, <strong>Goodpasture syndrome is a direct antibody-mediated (Type 2) disease</strong>, the <strong>Schultz-Dale phenomenon is an IgE-mediated (Type 1) model</strong>, and <strong>Lepra reaction 2 is an immune complex-mediated (Type 3) reaction.</strong></p>",
      "correct_choice_id": 201,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 22,
      "choices": [
        {
          "id": 211,
          "text": "<p><span style=\"font-size:12.0pt;\">Hereditary angioedema</span></p>"
        },
        {
          "id": 212,
          "text": "<p><span style=\"font-size:12.0pt;\">Goodpasture's syndrome</span></p>"
        },
        {
          "id": 213,
          "text": "<p><span style=\"font-size:12.0pt;\">Hay fever</span></p>"
        },
        {
          "id": 214,
          "text": "<p><span style=\"font-size:12.0pt;\">Contact dermatitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following are examples of hypersensitivity diseases except:</span></p>",
      "unique_key": "DT1181871",
      "question_audio": null,
      "question_video": null,
      "map_id": 1181871,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Hereditary angioedema </strong>is an inherited disorder caused by a deficiency or dysfunction of the C1 esterase inhibitor (C1-INH) protein, a key regulator of the complement, kinin, coagulation, and fibrinolytic pathways.</li>\n<li>This deficiency leads to uncontrolled activation of these pathways, resulting in excessive bradykinin production, which causes episodic swelling (angioedema).</li>\n<li>Therefore, it is classified as a primary immunodeficiency disorder, specifically an <strong>immune deficiency disease</strong>, not a hypersensitivity disease.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Goodpasture's syndrome (Option B):</strong> This is a serious autoimmune disease characterized by the presence of autoantibodies directed against the &alpha;3 chain of Type IV collagen in the basement membranes of the kidneys and lungs. This direct antibody-mediated tissue damage classifies it as a <strong>Type II hypersensitivity disease</strong>.</p>\n<p><strong>Hay fever (Option C):</strong> Also known as allergic rhinitis, hay fever is a common allergic reaction to airborne allergens (like pollen). It is mediated by IgE antibodies that trigger mast cell degranulation, leading to immediate symptoms like sneezing, runny nose, and itchy eyes. This makes it a classic example of a <strong>Type I hypersensitivity disease</strong>.</p>\n<p><strong>Contact dermatitis (Option D):</strong> This is an inflammatory skin reaction that occurs upon contact with certain allergens (e.g., nickel, poison ivy). It is mediated by T lymphocytes and typically develops 24-72 hours after exposure. This delayed, cell-mediated immune response classifies it as a <strong>Type IV hypersensitivity disease</strong>.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>While Goodpasture's syndrome, hay fever, and contact dermatitis are examples of Type II, Type I, and Type IV hypersensitivity diseases, respectively, <strong>hereditary angioedema is a distinct condition caused by a deficiency in C1 esterase inhibitor, making it an immune deficiency disease rather than a hypersensitivity disorder.</strong></p>",
      "correct_choice_id": 211,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23,
      "choices": [
        {
          "id": 221,
          "text": "<p><span style=\"font-size:12.0pt;\">Assertion is true, reason is true, reason is correct explanation for assertion</span></p>"
        },
        {
          "id": 222,
          "text": "<p><span style=\"font-size:12.0pt;\">Assertion is true, reason is true, reason is not correct explanation for assertion</span></p>"
        },
        {
          "id": 223,
          "text": "<p><span style=\"font-size:12.0pt;\">Assertion is true, reason is false</span></p>"
        },
        {
          "id": 224,
          "text": "<p><span style=\"font-size:12.0pt;\">Both assertion and reason are false</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Assertion and Reasoning Assertion: Not always mast cells are degranulated by crosslinking with IgE. Reason: NSAIDS, sometimes can directly activate mast cells.</span></p>",
      "unique_key": "DT1181887",
      "question_audio": null,
      "question_video": null,
      "map_id": 1181887,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Assertion is true:</strong> Mast cells are not exclusively degranulated by IgE crosslinking; other mechanisms exist.</li>\n<li><strong>Reason is true:</strong> Certain drugs, such as non-steroidal anti-inflammatory drugs (NSAIDS) and contrast agents, can directly activate mast cells, leading to mediator release.</li>\n<li>The <strong>reason correctly explains the assertion:</strong> The fact that NSAIDS can directly trigger mast cell degranulation provides a specific, valid mechanism that demonstrates how mast cell degranulation can occur independently of IgE crosslinking, thereby supporting the assertion. This type of reaction is termed \"anaphylactoid\" because it mimics the symptoms of anaphylaxis but is not IgE-mediated.</li>\n</ul>\n<p><strong>Key Takeaway:</strong></p>\n<p>While IgE crosslinking is the primary trigger for mast cell degranulation in allergic reactions, some drugs and substances can cause an anaphylactoid reaction by directly activating mast cells, demonstrating that the process is not always dependent on IgE.</p>",
      "correct_choice_id": 221,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24,
      "choices": [
        {
          "id": 231,
          "text": "<p><span style=\"font-size:12.0pt;\">Goodpasture syndrome</span></p>"
        },
        {
          "id": 232,
          "text": "<p><span style=\"font-size:12.0pt;\">Tuberculin reaction</span></p>"
        },
        {
          "id": 233,
          "text": "<p><span style=\"font-size:12.0pt;\">Arthus reaction</span></p>"
        },
        {
          "id": 234,
          "text": "<p><span style=\"font-size:12.0pt;\">Transfusion reaction</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A health care worker exposed to schistosome cercariae during a visit to an endemic area. IgG antibodies developed in response to the developing worms. When the adult worms released eggs into the circulation, the worker developed fever, edema, arthralgia, and a life-threatening rash. Which of the following immunologically mediated conditions arises by the same mechanism?</span></p>",
      "unique_key": "DT1181889",
      "question_audio": null,
      "question_video": null,
      "map_id": 1181889,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The clinical scenario describes a systemic reaction characterized by fever, edema, arthralgia, and rash that develops when a person with pre-existing <strong>IgG antibodies</strong> is re-exposed to a large quantity of antigen (in this case, eggs released by adult worms).</li>\n<li>The systemic symptoms are highly suggestive of an immune complex-mediated disease, which is a <strong>Type III hypersensitivity reaction</strong>.</li>\n<li>This type of reaction occurs when antigen-antibody complexes form in the bloodstream and deposit in various tissues, leading to inflammation and damage.</li>\n<li>The <strong>Arthus reaction </strong>is a localized example of a Type III hypersensitivity reaction. It occurs when a person with high levels of pre-existing IgG antibodies is exposed to an antigen in a specific location (e.g., intradermal injection), leading to the formation of local immune complexes that cause a severe inflammatory reaction.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Goodpasture syndrome (Option A):</strong> This is a Type II hypersensitivity reaction where autoantibodies directly target and destroy the basement membranes of the kidneys and lungs. This is a different mechanism from immune complex deposition.</p>\n<p><strong>Tuberculin reaction (Option B):</strong> This is a classic example of a Type IV, or delayed-type, hypersensitivity reaction, which is mediated by T lymphocytes and does not involve antibodies.</p>\n<p><strong>Transfusion reaction (Option D):</strong> An acute hemolytic transfusion reaction is a Type II hypersensitivity reaction, where pre-existing antibodies in the recipient's blood directly attack and destroy the red blood cells of the incompatible donor. This is also a different mechanism from immune complex deposition.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>The systemic symptoms of fever, rash, and joint pain arising from the formation of <strong>IgG antibody-antigen complexes</strong> in response to parasitic eggs are indicative of a <strong>Type III hypersensitivity reaction</strong>, which shares the same underlying mechanism as the <strong>Arthus reaction</strong>.</p>",
      "correct_choice_id": 233,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25,
      "choices": [
        {
          "id": 241,
          "text": "<p><span style=\"font-size:12.0pt;\">Type 1</span></p>"
        },
        {
          "id": 242,
          "text": "<p><span style=\"font-size:12.0pt;\">Type 2</span></p>"
        },
        {
          "id": 243,
          "text": "<p><span style=\"font-size:12.0pt;\">Type 3</span></p>"
        },
        {
          "id": 244,
          "text": "<p><span style=\"font-size:12.0pt;\">Type 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In an infected individual, on subsequent exposures, schistosome parasites are killed within minutes by an immune response which manifests in the skin as intense itching, stinging, and urticaria. This immune response is an example of which type of hypersensitivity?</span></p>",
      "unique_key": "DT1181898",
      "question_audio": null,
      "question_video": null,
      "map_id": 1181898,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The clinical scenario describes an immune response that occurs <strong>within minutes</strong> of a subsequent exposure and manifests with symptoms of <strong>intense itching, stinging, and urticaria (hives)</strong>. These signs are characteristic of an immediate-type allergic reaction.</li>\n<li><strong>Type 1 hypersensitivity</strong> is an immediate hypersensitivity reaction mediated by IgE antibodies. Upon initial exposure, the individual is sensitized, producing IgE antibodies that bind to mast cells and basophils. On subsequent exposures, the antigen (schistosome parasites) crosslinks these IgE antibodies on the surface of mast cells, triggering degranulation and the release of preformed mediators like histamine. Histamine is responsible for the rapid onset of symptoms such as itching, urticaria, and local swelling.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Type 2 (Option B):</strong> Type 2 hypersensitivity involves antibodies (IgG or IgM) directly targeting cell surfaces or extracellular matrix components, leading to cell destruction or dysfunction. This mechanism is not consistent with the described immediate, allergic-type symptoms.</p>\n<p><strong>Type 3 (Option C):</strong> Type 3 hypersensitivity is caused by the deposition of immune complexes in tissues, which leads to inflammation and damage, typically with a more delayed onset (hours to days) and systemic symptoms like fever and joint pain. This does not match the rapid urticarial reaction described.</p>\n<p><strong>Type 4 (Option D):</strong> Type 4 hypersensitivity is a cell-mediated, delayed-type reaction that takes 24 to 72 hours to develop. It does not involve antibodies and is not responsible for the immediate symptoms of itching and hives.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p>The rapid onset and characteristic symptoms of <strong>intense itching, stinging, and urticaria on subsequent exposure</strong> are classic signs of an immediate allergic reaction, which is mediated by IgE antibodies and is therefore classified as a <strong>Type 1 hypersensitivity reaction</strong>.</p>",
      "correct_choice_id": 241,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 26,
      "choices": [
        {
          "id": 251,
          "text": "<p><span style=\"font-size:12.0pt;\">Antihistamine</span></p>"
        },
        {
          "id": 252,
          "text": "<p><span style=\"font-size:12.0pt;\">Theophylline</span></p>"
        },
        {
          "id": 253,
          "text": "<p><span style=\"font-size:12.0pt;\">Epinephrine</span></p>"
        },
        {
          "id": 254,
          "text": "<p><span style=\"font-size:12.0pt;\">IgE Blocking antibody</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A young student immediately felt difficulty in breathing and tightness in his chest. He started sweating and fainted. His friends found out that a bee had just stung him. The emergency school medical team attended him and within minutes he recovered. Which one of the following drugs was administered by the medical team?</span></p>",
      "unique_key": "DT1181900",
      "question_audio": null,
      "question_video": null,
      "map_id": 1181900,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The student's symptoms of difficulty breathing, chest tightness, sweating, and fainting immediately after a bee sting are classic signs of a severe, life-threatening allergic reaction called anaphylaxis. The fact that the student recovered within minutes points to the administration of a fast-acting emergency treatment.</li>\n<li><strong>Epinephrine </strong>is the drug of choice for treating anaphylaxis. It acts as a physiological antagonist to the effects of histamine and other mediators released during the reaction. Its key actions are:\n<ul>\n<li><strong>Alpha-1 adrenergic effects:</strong> Cause vasoconstriction, which helps to increase blood pressure, reduce swelling, and prevent shock.</li>\n<li><strong>Beta-2 adrenergic effects:</strong> Cause bronchodilation, which relaxes the smooth muscles of the airways and relieves the difficulty in breathing and chest tightness.</li>\n<li><strong>Beta-1 adrenergic effects:</strong> Increase heart rate and contractility, which helps to counteract the cardiovascular collapse.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Antihistamine (Option A):</strong> This is a suitable treatment for mild allergic reactions like hives but is not fast or potent enough to reverse the severe, systemic symptoms of anaphylaxis.</p>\n<p><strong>Theophylline (Option B):</strong> This is a bronchodilator used for managing conditions like asthma but is not a first-line treatment for an acute anaphylactic emergency due to its slower onset of action.</p>\n<p><strong>IgE Blocking antibody (Option D):</strong> This is used for the long-term management of severe asthma and chronic urticaria and is not indicated for acute, emergency situations.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>Epinephrine is the essential first-line treatment for anaphylaxis</strong> due to its rapid and comprehensive effects that reverse bronchospasm, increase blood pressure, and counteract the life-threatening symptoms of a severe allergic reaction.</p>",
      "correct_choice_id": 253,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 27,
      "choices": [
        {
          "id": 261,
          "text": "<p><span style=\"font-size:12.0pt;\">Autoimmune hemolytic anemia</span></p>"
        },
        {
          "id": 262,
          "text": "<p><span style=\"font-size:12.0pt;\">Goodpasture syndrome</span></p>"
        },
        {
          "id": 263,
          "text": "<p><span style=\"font-size:12.0pt;\">Myasthenia gravis</span></p>"
        },
        {
          "id": 264,
          "text": "<p><span style=\"font-size:12.0pt;\">Systemic lupus erythematosus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following Type 3 hypersensitivity mediated diseases shows antigen-antibody complexes deposition in joints, blood vessels, or kidney?</span></p>",
      "unique_key": "DT1181902",
      "question_audio": null,
      "question_video": null,
      "map_id": 1181902,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Systemic lupus erythematosus (SLE) </strong>is a classic example of a Type III hypersensitivity disease.</li>\n<li>It is a multisystem autoimmune disorder where the immune system produces a wide range of autoantibodies, including those against nuclear antigens (e.g., anti-dsDNA).</li>\n<li>These antibodies form circulating immune complexes with antigens. The deposition of these immune complexes in various tissues, such as the glomeruli of the kidneys, the lining of the joints, and the walls of blood vessels, triggers inflammation and tissue damage, leading to the diverse clinical manifestations of the disease.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Autoimmune hemolytic anemia (Option A):</strong> This is a Type II hypersensitivity reaction where antibodies are directed against antigens on the surface of red blood cells, leading to their destruction.</p>\n<p><strong>Goodpasture syndrome (Option B):</strong> This is a Type II hypersensitivity reaction where autoantibodies directly target the basement membrane in the kidneys and lungs.</p>\n<p><strong>Myasthenia gravis (Option C):</strong> This is a Type II hypersensitivity reaction where autoantibodies bind to acetylcholine receptors at the neuromuscular junction, blocking the transmission of nerve signals.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>Systemic lupus erythematosus (SLE) is a prime example of a Type III hypersensitivity disease</strong> because its widespread organ damage is caused by the systemic deposition of circulating antigen-antibody complexes, particularly in the kidneys, joints, and blood vessels.</p>",
      "correct_choice_id": 264,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 28,
      "choices": [
        {
          "id": 271,
          "text": "<p><span style=\"font-size:12.0pt;\">Antihistamine</span></p>"
        },
        {
          "id": 272,
          "text": "<p><span style=\"font-size:12.0pt;\">Theophylline</span></p>"
        },
        {
          "id": 273,
          "text": "<p><span style=\"font-size:12.0pt;\">Epinephrine</span></p>"
        },
        {
          "id": 274,
          "text": "<p><span style=\"font-size:12.0pt;\">Blocking antibody</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A young student immediately felt difficulty in breathing and tightness in his chest. He started sweating and fainted. His friends found out that a bee had just stung him. The emergency school medical team attended him and within minutes he recovered. Which one of the following would help to desensitise the student?</span></p>",
      "unique_key": "DT1181905",
      "question_audio": null,
      "question_video": null,
      "map_id": 1181905,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The question describes a student who experienced anaphylaxis from a bee sting and asks about a method for desensitization, which is the process of reducing an allergic person's sensitivity to an allergen.</li>\n<li><strong>Blocking antibody </strong>is the correct answer because it is the central component of allergen immunotherapy, the medical process of desensitization.</li>\n<li>In this process, the patient is given gradually increasing doses of the allergen over time. This treatment aims to shift the immune response away from producing IgE antibodies and towards producing IgG antibodies, specifically a type of IgG called a \"blocking antibody.\"</li>\n<li>When the patient is later exposed to the allergen naturally, these IgG blocking antibodies bind to the allergen before it can reach and crosslink the IgE antibodies on mast cells, thereby preventing mast cell degranulation and the subsequent allergic reaction.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Antihistamine (Option A):</strong> This is used for symptomatic relief by blocking the effects of histamine after it has been released and does not alter the underlying allergic response or prevent a future attack.</p>\n<p><strong>Theophylline (Option B):</strong> This is a bronchodilator used to manage respiratory symptoms but is not a method for desensitization.</p>\n<p><strong>Epinephrine (Option C):</strong> This is a life-saving drug used to treat the acute, emergency symptoms of anaphylaxis and does not provide long-term desensitization.</p>\n<p><strong>Key Takeaway:</strong></p>\n<p><strong>Desensitization (allergen immunotherapy) works by inducing the production of IgG \"blocking antibodies,\" which compete with IgE for the allergen</strong>, thereby preventing mast cell degranulation and allergic symptoms upon subsequent exposures.</p>",
      "correct_choice_id": 274,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}